blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2570813

EP2570813 - METHOD FOR THE DIAGNOSIS/PROGNOSIS OF COLORECTAL CANCER [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.04.2021
Database last updated on 11.09.2024
FormerThe patent has been granted
Status updated on  15.05.2020
FormerGrant of patent is intended
Status updated on  18.12.2019
FormerExamination is in progress
Status updated on  10.11.2017
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024 [2024/41]
Applicant(s)For all designated states
Consejo Superior De Investigaciones Científicas (CSIC)
Serrano 117
28006 Madrid / ES
[N/P]
Former [2020/25]For all designated states
Consejo Superior De Investigaciones Científicas (CSIC)
Serrano 117
28006 Madrid / ES
Former [2013/12]For all designated states
Consejo Superior De Investigaciones Científicas
C/ Serrano N° 117
28006 Madrid / ES
Inventor(s)01 / CASAL ÁLVAREZ, José Ignacio
Laboratorio de Proteómica Funcional
Centro de Investigaciones Biológicas (CSIC)
C/ Ramiro de Maeztu, 9
E-28040 Madrid / ES
02 / BARDERAS MANCHADO, Rodrigo
Laboratorio de Proteómica Funcional
Centro de Investigaciones Biológicas (CSIC)
C/ Ramiro de Maeztu, 9
E-28040 Madrid / ES
03 / BABEL, Ingrid Henriette Suzanne
Laboratorio de Proteómica Funcional
Centro de Investigaciones Biológicas (CSIC)
C/ Ramiro de Maeztu, 9
E-28040 Madrid / ES
 [2020/03]
Former [2013/12]01 / CASAL ÁLVAREZ, José Ignacio
Laboratorio de Proteómica Funcional
Centro de Investigaciones Biológicas (CSIC)
C/ Ramiro de Maeztu 9
E-28040 Madrid / ES
02 / BARDERAS MANCHADO, Rodrigo
Laboratorio de Proteómica Funcional
Centro de Investigaciones Biológicas (CSIC)
C/ Ramiro de Maeztu 9
E-28040 Madrid / ES
03 / BABEL, Ingrid Henriette Suzanne
Laboratorio de Proteómica Funcional
Centro de Investigaciones Biológicas (CSIC)
C/ Ramiro de Maeztu 9
E-28040 Madrid / ES
Representative(s)ABG Intellectual Property Law, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
[2020/25]
Former [2013/12]ABG Patentes, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
Application number, filing date11780257.913.05.2011
[2020/25]
WO2011ES70346
Priority number, dateES2010003070813.05.2010         Original published format: ES 201030708
[2013/12]
Filing languageES
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011141612
Date:17.11.2011
Language:ES
[2011/46]
Type: A2 Application without search report 
No.:EP2570813
Date:20.03.2013
Language:EN
[2013/12]
Type: B1 Patent specification 
No.:EP2570813
Date:17.06.2020
Language:EN
[2020/25]
Search report(s)International search report - published on:ES05.01.2012
(Supplementary) European search report - dispatched on:EP13.11.2013
ClassificationIPC:G01N33/574
[2013/12]
CPC:
G01N33/57419 (EP,US); G01N33/564 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/12]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERFAHREN ZUR DIAGNOSE/PROGNOSE VON DARMKREBS[2013/12]
English:METHOD FOR THE DIAGNOSIS/PROGNOSIS OF COLORECTAL CANCER[2013/12]
French:MÉTHODE DE DIAGNOSTIC/PRONOSTIC DU CANCER COLORECTAL[2013/12]
Entry into regional phase12.12.2012Translation filed 
12.12.2012National basic fee paid 
12.12.2012Search fee paid 
12.12.2012Designation fee(s) paid 
12.12.2012Examination fee paid 
Examination procedure12.12.2012Examination requested  [2013/12]
28.05.2014Amendment by applicant (claims and/or description)
09.02.2016Despatch of a communication from the examining division (Time limit: M04)
20.06.2016Reply to a communication from the examining division
02.11.2017Despatch of a communication from the examining division (Time limit: M04)
12.03.2018Reply to a communication from the examining division
13.11.2019Cancellation of oral proceeding that was planned for 18.11.2019
18.11.2019Date of oral proceedings (cancelled)
19.12.2019Communication of intention to grant the patent
16.04.2020Fee for grant paid
16.04.2020Fee for publishing/printing paid
16.04.2020Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.02.2016
Opposition(s)18.03.2021No opposition filed within time limit [2021/21]
Fees paidRenewal fee
10.05.2013Renewal fee patent year 03
07.03.2014Renewal fee patent year 04
12.03.2015Renewal fee patent year 05
17.05.2016Renewal fee patent year 06
18.05.2017Renewal fee patent year 07
03.05.2018Renewal fee patent year 08
09.05.2019Renewal fee patent year 09
11.05.2020Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.05.2011
AL17.06.2020
AT17.06.2020
CY17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
MC17.06.2020
MK17.06.2020
MT17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
TR17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
[2024/41]
Former [2024/29]HU13.05.2011
AL17.06.2020
AT17.06.2020
CY17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
MC17.06.2020
MK17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
TR17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
Former [2024/22]HU13.05.2011
AL17.06.2020
AT17.06.2020
CY17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
MC17.06.2020
MK17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
Former [2023/29]HU13.05.2011
AL17.06.2020
AT17.06.2020
CY17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
MC17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
Former [2023/24]AL17.06.2020
AT17.06.2020
CY17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
MC17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
Former [2022/07]AL17.06.2020
AT17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
MC17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
Former [2021/24]AL17.06.2020
AT17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SI17.06.2020
SK17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
Former [2021/20]AL17.06.2020
AT17.06.2020
CZ17.06.2020
DK17.06.2020
EE17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SK17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
Former [2021/10]AL17.06.2020
AT17.06.2020
CZ17.06.2020
EE17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
NL17.06.2020
PL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SK17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
IS17.10.2020
PT19.10.2020
Former [2021/09]AL17.06.2020
AT17.06.2020
CZ17.06.2020
EE17.06.2020
FI17.06.2020
HR17.06.2020
IT17.06.2020
LT17.06.2020
LV17.06.2020
NL17.06.2020
RO17.06.2020
RS17.06.2020
SE17.06.2020
SM17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
PT19.10.2020
Former [2021/04]AL17.06.2020
FI17.06.2020
HR17.06.2020
LT17.06.2020
LV17.06.2020
NL17.06.2020
RS17.06.2020
SE17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
Former [2021/01]FI17.06.2020
HR17.06.2020
LT17.06.2020
LV17.06.2020
RS17.06.2020
SE17.06.2020
BG17.09.2020
NO17.09.2020
GR18.09.2020
Former [2020/51]FI17.06.2020
HR17.06.2020
LT17.06.2020
LV17.06.2020
RS17.06.2020
SE17.06.2020
NO17.09.2020
GR18.09.2020
Former [2020/50]FI17.06.2020
HR17.06.2020
LT17.06.2020
LV17.06.2020
SE17.06.2020
NO17.09.2020
GR18.09.2020
Former [2020/48]FI17.06.2020
LT17.06.2020
SE17.06.2020
NO17.09.2020
Former [2020/47]LT17.06.2020
NO17.09.2020
Documents cited:Search[XAI]WO2009008496  (DAIICHI SANKYO CO LTD [JP], et al) [X] 8,10-12 * the whole document * [A] 1-7 [I] 9,13,14;
 [A]WO2009040782  (ROYAL COLLEGE OF SURGEONS IE [IE], et al) [A] 1-14 * p. 2, 2nd paragraph - p. 13, 2nd paragraph, p. 22, line 1 - p. 29, line 3 *;
 [AD]  - BABEL INGRID ET AL, "Identification of Tumor-associated Autoantigens for the Diagnosis of Colorectal Cancer in Serum Using High Density Protein Microarrays", MOLECULAR & CELLULAR PROTEOMICS, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, vol. 8, no. 10, doi:10.1074/MCP.M800596-MCP200, ISSN 1535-9476, (20091001), pages 2382 - 2395, (20090828), XP009137622 [AD] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1074/mcp.M800596-MCP200
 [A]  - RAN YULIANG ET AL, "Profiling tumor-associated autoantibodies for the detection of colon cancer", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, (20080501), vol. 14, no. 9, doi:10.1158/1078-0432.CCR-07-2021, ISSN 1078-0432, pages 2696 - 2700, XP002596849 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1158/1078-0432.CCR-07-2021
 [A]  - SOMERS VEERLE A ET AL, "A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, (20020901), vol. 169, no. 5, ISSN 0022-1767, pages 2772 - 2780, XP002517011 [A] 1-14 * the whole document *
 [A]  - KIJANKA G ET AL, "Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer", GUT, (201001), vol. 59, no. 1, ISSN 0017-5749, pages 69 - 78, XP009173900 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1136/gut.2009.178574
 [A]  - REIPING TANG ET AL, "Humoral response to p53 in human colorectal tumors: A prospective study of 1,209 patients", INTERNATIONAL JOURNAL OF CANCER, (20011215), vol. 94, no. 6, doi:10.1002/ijc.1541, ISSN 0020-7136, pages 859 - 863, XP055085702 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1002/ijc.1541
 [A]  - CHUNG-CHUAN CHAN ET AL, "Multiple serological biomarkers for colorectal cancer detection", INTERNATIONAL JOURNAL OF CANCER, (20100101), doi:10.1002/ijc.24912, ISSN 0020-7136, pages NA - NA, XP055086360 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1002/ijc.24912
 [A]  - ROB C. ROOVERS ET AL, "Evidence for a bias toward intracellular antigens in the local humoral anti-tumor immune response of a colorectal cancer patient revealed by phage display", INTERNATIONAL JOURNAL OF CANCER, (20010915), vol. 93, no. 6, doi:10.1002/ijc.1382, ISSN 0020-7136, pages 832 - 840, XP055085819 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1002/ijc.1382
 [A]  - JAN FRIEDERICHS ET AL, "Gene expression profiles of different clinical stages of colorectal carcinoma: toward a molecular genetic understanding of tumor progression", INTERNATIONAL JOURNAL OF COLORECTAL DISEASE ; CLINICAL AND MOLECULAR GASTROENTEROLOGY AND SURGERY, SPRINGER, BERLIN, DE, (20050901), vol. 20, no. 5, doi:10.1007/S00384-004-0722-1, ISSN 1432-1262, pages 391 - 402, XP019340240 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1007/s00384-004-0722-1
 [AD]  - MADOZ-GURPIDE J ET AL, "Proteomics-based validation of genomic data: applications in colorectal cancer diagnosis", MOLECULAR & CELLULAR PROTEOMICS, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, (20060529), vol. 5, no. 8, doi:10.1074/MCP.M600048-MCP200, ISSN 1535-9476, pages 1471 - 1483, XP002463510 [AD] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1074/mcp.M600048-MCP200
 [A]  - CARDOSO ET AL, "Expression and genomic profiling of colorectal cancer", BBA - REVIEWS ON CANCER, ELSEVIER SCIENCE BV, AMSTERDAM, NL, (20061213), vol. 1775, no. 1, doi:10.1016/J.BBCAN.2006.08.004, ISSN 0304-419X, pages 103 - 137, XP005802353 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.bbcan.2006.08.004
 [A]  - KALNINA Z ET AL, "Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 334, no. 1-2, doi:10.1016/J.JIM.2008.01.022, ISSN 0022-1759, (20080520), pages 37 - 50, (20080221), XP022614832 [A] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jim.2008.01.022
 [XP]  - W. CHANG ET AL, "Development of Autoantibody Signatures as Biomarkers for Early Detection of Colorectal Carcinoma", CLINICAL CANCER RESEARCH, (20110719), vol. 17, no. 17, doi:10.1158/1078-0432.CCR-11-0199, ISSN 1078-0432, pages 5715 - 5724, XP055085848 [XP] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1158/1078-0432.CCR-11-0199
International search[A]  - KLEIN-SCORY, S. ET AL., "Immunoscreening of the extracellular proteome of colorectal cancer cells.", BMC CANCER, (20100225), vol. 10, doi:doi:10.1186/1471-2407-10-70, page 70, XP021066952

DOI:   http://dx.doi.org/10.1186/1471-2407-10-70
 [A]  - BABEL, I. ET AL., "Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.", MOLECULAR & CELLULAR PROTEOMICS, (200910), vol. 8, no. 10, doi:doi:10.1074/mcp.M800596-MCP200, pages 2382 - 2395, XP009137622

DOI:   http://dx.doi.org/10.1074/mcp.M800596-MCP200
 [A]  - CHAN, C.C. ET AL., "Multiple serological biomarkers for colorectal cancer detection.", INTERNATIONAL JOURNAL OF CANCER, (201004), vol. 126, no. 7, pages 1683 - 1690
 [A]  - BARDERAS, R. ET AL., "Colorectal cancer proteomics, molecular characterization and biomarker discovery", PROTEOMICS CLINICAL APPLICATIONS, (201002), vol. 4, no. 2, pages 159 - 178
 [A]  - TAN, H.T. ET AL., "Serum autoantibodies as biomarkers for early cancer detection.", FEBS JOURNAL, (2009), vol. 276, no. 23, doi:doi:10.1111/j.1742-4658.2009.07396.x, pages 6880 - 6904, XP055067154

DOI:   http://dx.doi.org/10.1111/j.1742-4658.2009.07396.x
 [XP]  - BABEL, I. ET AL., "Identification of MSTl/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays", MOLECULAR & CELLULAR PROTEOMICS, (201103), vol. 10, no. 3, doi:doi:10.1074/mcp.M110.001784, page M110.001784, XP055085854

DOI:   http://dx.doi.org/10.1074/mcp.M110.001784
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.